Last reviewed · How we verify
Ddimer testing
At a glance
| Generic name | Ddimer testing |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Diagnosis Exclusion of Recurrent Deep Vein Thrombosis of the Lower Limbs (NA)
- Evaluation of a Point-of-care Lateral Flow Assay in Glial Fibrillary Acidic Protein (GFAP) and D-dimer in Diagnosis of Large Vessel Occlusion Acute Ischemic Stroke in a Pediatric Hospital
- Integrating AI Predictions With Clinician Expertise (NA)
- Study of Hemostasis in Patients With Congenital Disorder of Glycosylation
- Diagnostic Strategy for Suspected Pulmonary Embolism Based on 4PEPS (NA)
- Hyperspectral Analysis of Sweat Metabolite Biometrics for Real-Time Detection of COVID-19
- Early Warning and Classification Model for Acute Non-traumatic Chest Pain
- Thrombo-Elastography Guided Management of ECMO
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |